Samsara BioCapital, L.P. 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-08 8:05 pm Purchase | 2025-09-04 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 6,346,194 8.200% | 609,889 (+10.63%) | Filing |
| 2025-03-17 9:06 pm Purchase | 2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 5,736,305 9.100% | 644,278 (+12.65%) | Filing |
| 2024-02-12 4:48 pm Purchase | 2024-02-12 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 5,092,027 10.300% | 5,092,027 (New Position) | Filing |